title: Change or die: targeting adaptive signaling to kinase inhibition in cancer cells.
abstract: Small molecule kinase inhibitors have proven enormously successful at delivering impressive responses in patients with cancers as diverse as chronic myeloid-leukemia, melanoma, breast cancer and small cell lung cancer. Despite this, resistance is commonplace and most patients ultimately fail therapy. One emerging observation is the rapid rewiring of signaling that occurs across multiple cancer types when driver oncogene function is inhibited. These adaptive signaling changes seem critical in delivering some of the earliest survival signals that allow small numbers of cells to evade therapy. In this commentary we review the mechanisms that contribute to the robustness of signaling networks within cancer cells and suggest new therapeutic strategies to limit treatment failure.
authors.affiliation: The Department of Molecular Oncology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States.
authors.forename: Vito W
authors.initials: VW
authors.lastname: Rebecca
authors.affiliation: The Department of Molecular Oncology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States; Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States. Electronic address: keiran.smalley@moffitt.org.
authors.forename: Keiran S M
authors.initials: KS
authors.lastname: Smalley
mesh_terms: D000222:Adaptation, Physiological; D006801:Humans; D009369:Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D047428:Protein Kinase Inhibitors; D011494:Protein Kinases
keywords: BRAF; Melanoma; NRAS; Phosphoproteomics; Signaling
references.citation: FEBS J. 2013 Jan;280(2):489-504
references.pmid: 22812510
references.citation: Oncogene. 2005 May 12;24(21):3459-71
references.pmid: 15735667
references.citation: Cancer Res. 2004 Aug 15;64(16):5556-9
references.pmid: 15313890
references.citation: Curr Top Microbiol Immunol. 1998;228:179-208
references.pmid: 9401207
references.citation: Mol Cancer Ther. 2014 Feb;13(2):353-63
references.pmid: 24398428
references.citation: J Clin Invest. 2011 Nov;121(11):4311-21
references.pmid: 21985784
references.citation: Cancer Cell. 2014 May 12;25(5):697-710
references.pmid: 24746704
references.citation: Nat Rev Cancer. 2003 Jan;3(1):11-22
references.pmid: 12509763
references.citation: Cell. 1995 Dec 15;83(6):879-88
references.pmid: 8521512
references.citation: Oncogene. 2006 Oct 16;25(48):6373-83
references.pmid: 17041623
references.citation: Mol Endocrinol. 2000 Jun;14(6):783-94
references.pmid: 10847581
references.citation: Cell. 2001 Feb 23;104(4):593-604
references.pmid: 11239415
references.citation: Oncogene. 2013 May 9;32(19):2373-9
references.pmid: 22945644
references.citation: Mol Cancer Ther. 2010 Jul;9(7):1956-67
references.pmid: 20571069
references.citation: N Engl J Med. 2012 Jul 12;367(2):107-14
references.pmid: 22663011
references.citation: Adv Cancer Res. 2008;100:35-83
references.pmid: 18620092
references.citation: Endocr Relat Cancer. 2001 Sep;8(3):161-73
references.pmid: 11566607
references.citation: Nature. 2012 Jul 26;487(7408):500-4
references.pmid: 22763439
references.citation: Sci Transl Med. 2011 Jul 6;3(90):90ra59
references.pmid: 21734175
references.citation: Science. 2011 Jun 10;332(6035):1322-6
references.pmid: 21659605
references.citation: Clin Cancer Res. 2011 Aug 1;17(15):5132-9
references.pmid: 21558407
references.citation: Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44
references.pmid: 18715233
references.citation: Biochem Pharmacol. 2010 Sep 1;80(5):613-23
references.pmid: 20519133
references.citation: Sci Transl Med. 2010 Jan 27;2(16):16ra7
references.pmid: 20371474
references.citation: Nat Rev Cancer. 2003 Jun;3(6):459-65
references.pmid: 12778136
references.citation: J Clin Invest. 2008 Sep;118(9):3065-74
references.pmid: 18725988
references.citation: Nature. 2013 May 30;497(7451):638-42
references.pmid: 23698361
references.citation: J Natl Cancer Inst. 2013 May 1;105(9):606-7
references.pmid: 23535073
references.citation: J Clin Oncol. 2002 Mar 15;20(6):1692-703
references.pmid: 11896121
references.citation: Mol Cell Proteomics. 2014 Jul;13(7):1844-54
references.pmid: 24760959
references.citation: Cancer Res. 2009 Sep 1;69(17):6773-81
references.pmid: 19690147
references.citation: Nature. 2010 Dec 16;468(7326):973-7
references.pmid: 21107323
references.citation: Nat Rev Mol Cell Biol. 2004 Nov;5(11):875-85
references.pmid: 15520807
references.citation: Nature. 2012 Jan 26;483(7387):100-3
references.pmid: 22281684
references.citation: J Clin Oncol. 2011 Aug 1;29(22):3085-96
references.pmid: 21383288
references.citation: Science. 2002 May 31;296(5573):1655-7
references.pmid: 12040186
references.citation: Proc Natl Acad Sci U S A. 2011 May 3;108(18):7535-40
references.pmid: 21502504
references.citation: Sci Signal. 2010 Dec 21;3(153):ra90
references.pmid: 21177493
references.citation: Annu Rev Biochem. 1993;62:851-91
references.pmid: 8352603
references.citation: Pigment Cell Melanoma Res. 2009 Aug;22(4):400-19
references.pmid: 19493313
references.citation: Genes Cancer. 2011 Mar;2(3):298-305
references.pmid: 21779500
references.citation: Nat Rev Drug Discov. 2007 Jul;6(7):541-55
references.pmid: 17585331
references.citation: Curr Biol. 2002 Apr 30;12(9):R325-7
references.pmid: 12007434
references.citation: J Biol Chem. 2001 Dec 7;276(49):46460-8
references.pmid: 11585837
references.citation: Science. 2011 Jun 10;332(6035):1317-22
references.pmid: 21659604
references.citation: N Engl J Med. 2011 Jun 16;364(24):2305-15
references.pmid: 21663470
references.citation: N Engl J Med. 2011 Jun 30;364(26):2507-16
references.pmid: 21639808
references.citation: Science. 2004 Apr 23;304(5670):554
references.pmid: 15016963
references.citation: Nature. 2002 Jun 27;417(6892):949-54
references.pmid: 12068308
references.citation: Blood. 2007 Apr 15;109(8):3509-12
references.pmid: 17179228
references.citation: Oncogene. 2012 May 10;31(19):2471-9
references.pmid: 21996740
references.citation: Cell. 2008 May 2;133(3):403-14
references.pmid: 18455982
references.citation: Cancer Discov. 2013 May;3(5):520-33
references.pmid: 23365119
references.citation: Oncogene. 2008 May 1;27(20):2934-40
references.pmid: 18059341
references.citation: Clin Cancer Res. 2012 Jul 1;18(13):3592-602
references.pmid: 22553343
references.citation: J Clin Invest. 2001 Mar;107(6):727-35
references.pmid: 11254672
references.citation: Cancer Discov. 2011 Aug;1(3):248-59
references.pmid: 22140653
references.citation: J Clin Endocrinol Metab. 2003 Sep;88(9):4393-7
references.pmid: 12970315
references.citation: Nature. 2010 Dec 16;468(7326):968-72
references.pmid: 21107320
references.citation: Biochem Pharmacol. 2010 Sep 1;80(5):575-83
references.pmid: 20385106
references.citation: J Clin Invest. 2013 May;123(5):2155-68
references.pmid: 23543055
references.citation: Cancer Discov. 2014 Jan;4(1):80-93
references.pmid: 24265155
references.citation: Diabetes. 2001 Jan;50(1):24-31
references.pmid: 11147790
references.citation: Nature. 2007 Jan 25;445(7126):437-41
references.pmid: 17206155
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6
references.pmid: 18287029
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4519-24
references.pmid: 19251651
references.citation: Cancer Discov. 2014 Jan;4(1):61-8
references.pmid: 24265154
references.citation: Nature. 2010 Sep 30;467(7315):596-9
references.pmid: 20823850
references.citation: Cancer Res. 2006 Feb 1;66(3):1500-8
references.pmid: 16452206
references.citation: Clin Cancer Res. 2012 May 1;18(9):2502-14
references.pmid: 22351686
references.citation: Cancer Discov. 2013 Aug;3(8):862-9
references.pmid: 23612012
references.citation: Mol Cancer Ther. 2005 Oct;4(10):1533-40
references.pmid: 16227402
references.citation: Br J Cancer. 2010 Jun 8;102(12):1724-30
references.pmid: 20531415
references.citation: Nat Rev Mol Cell Biol. 2004 Jun;5(6):441-50
references.pmid: 15173823
references.citation: J Natl Cancer Inst. 2003 Mar 19;95(6):484-6
references.pmid: 12644542
references.citation: Am J Pathol. 2002 May;160(5):1567-72
references.pmid: 12000708
references.citation: Cancer Res. 2006 Dec 1;66(23):11100-5
references.pmid: 17145850
references.citation: Cancer Cell. 2012 Nov 13;22(5):668-82
references.pmid: 23153539
references.citation: PLoS One. 2013;8(2):e56134
references.pmid: 23418523
references.citation: Cancer Res. 2013 Jul 1;73(13):4050-4060
references.pmid: 23667175
references.citation: Cancer Cell. 2010 Dec 14;18(6):683-95
references.pmid: 21156289
references.citation: N Engl J Med. 2004 May 20;350(21):2129-39
references.pmid: 15118073
references.citation: Nature. 2013 Nov 28;503(7477):548-51
references.pmid: 24256730
references.citation: Cancer Res. 2009 Mar 15;69(6):2224-33
references.pmid: 19244113
references.citation: N Engl J Med. 2001 Apr 5;344(14):1031-7
references.pmid: 11287972
references.citation: Cell. 2008 Jun 27;133(7):1292-1292.e1
references.pmid: 18585361
references.citation: N Engl J Med. 2012 Nov;367(18):1694-703
references.pmid: 23020132
references.citation: N Engl J Med. 2002 Aug 15;347(7):472-80
references.pmid: 12181401
references.citation: J Clin Invest. 2014 Mar;124(3):1406-17
references.pmid: 24569374
references.citation: N Engl J Med. 2010 Oct 28;363(18):1693-703
references.pmid: 20979469
references.citation: Lancet. 2012 Jul 28;380(9839):358-65
references.pmid: 22735384
references.citation: Br J Haematol. 2011 Jun;153(6):729-40
references.pmid: 21534941
references.citation: Clin Cancer Res. 2013 Feb 1;19(3):657-67
references.pmid: 23251002
references.citation: Cancer Cell. 2011 Jan 18;19(1):45-57
references.pmid: 21215707
references.citation: Curr Biol. 2004 Jul 27;14(14):1296-302
references.pmid: 15268862
references.citation: Cell. 2012 Apr 13;149(2):307-21
references.pmid: 22500798
references.citation: Genes Dev. 1998 Nov 15;12(22):3499-511
references.pmid: 9832503
references.citation: Cancer Res. 2008 Jul 15;68(14):5827-38
references.pmid: 18632637
references.citation: Cancer Cell. 2011 Jan 18;19(1):58-71
references.pmid: 21215704
references.citation: Nature. 1999 Sep 9;401(6749):173-7
references.pmid: 10490027